JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/01/30 | 1,041 | 1,065 | 1,038 | 1,052 | +22 | +2.1% | 1,113,800 |
2024/01/29 | 1,045 | 1,056 | 1,018 | 1,030 | -75 | -6.8% | 2,294,700 |
2024/01/26 | 1,120 | 1,120 | 1,097 | 1,105 | -16 | -1.4% | 828,100 |
2024/01/25 | 1,134 | 1,136 | 1,092 | 1,121 | -27 | -2.4% | 1,028,900 |
2024/01/24 | 1,152 | 1,167 | 1,145 | 1,148 | -2 | -0.2% | 337,900 |
2024/01/23 | 1,175 | 1,188 | 1,150 | 1,150 | -11 | -0.9% | 283,800 |
2024/01/22 | 1,156 | 1,170 | 1,149 | 1,161 | +10 | +0.9% | 326,500 |
2024/01/19 | 1,165 | 1,167 | 1,148 | 1,151 | -7 | -0.6% | 290,500 |
2024/01/18 | 1,165 | 1,167 | 1,144 | 1,158 | -13 | -1.1% | 447,900 |
2024/01/17 | 1,195 | 1,213 | 1,171 | 1,171 | -35 | -2.9% | 511,000 |
2024/01/16 | 1,201 | 1,219 | 1,199 | 1,206 | +3 | +0.2% | 307,500 |
2024/01/15 | 1,216 | 1,216 | 1,191 | 1,203 | -12 | -1% | 437,800 |
2024/01/12 | 1,224 | 1,228 | 1,198 | 1,215 | +1 | +0.1% | 323,000 |
2024/01/11 | 1,208 | 1,223 | 1,198 | 1,214 | +19 | +1.6% | 359,500 |
2024/01/10 | 1,165 | 1,200 | 1,158 | 1,195 | +40 | +3.5% | 407,800 |
2024/01/09 | 1,147 | 1,167 | 1,143 | 1,155 | +13 | +1.1% | 290,800 |
2024/01/05 | 1,177 | 1,178 | 1,142 | 1,142 | -44 | -3.7% | 462,000 |
2024/01/04 | 1,168 | 1,193 | 1,146 | 1,186 | +14 | +1.2% | 420,900 |
2023/12/29 | 1,179 | 1,188 | 1,164 | 1,172 | -5 | -0.4% | 247,100 |
2023/12/28 | 1,145 | 1,177 | 1,132 | 1,177 | +40 | +3.5% | 306,500 |
2023/12/27 | 1,114 | 1,139 | 1,101 | 1,137 | +17 | +1.5% | 441,000 |
2023/12/26 | 1,111 | 1,130 | 1,111 | 1,120 | +13 | +1.2% | 375,700 |
2023/12/25 | 1,120 | 1,125 | 1,098 | 1,107 | -15 | -1.3% | 375,200 |
2023/12/22 | 1,135 | 1,146 | 1,121 | 1,122 | +1 | +0.1% | 276,900 |
2023/12/21 | 1,132 | 1,144 | 1,117 | 1,121 | -20 | -1.8% | 343,500 |
2023/12/20 | 1,157 | 1,161 | 1,136 | 1,141 | -12 | -1% | 333,700 |
2023/12/19 | 1,145 | 1,155 | 1,136 | 1,153 | +13 | +1.1% | 271,200 |
2023/12/18 | 1,131 | 1,151 | 1,111 | 1,140 | -12 | -1% | 423,300 |
2023/12/15 | 1,174 | 1,180 | 1,142 | 1,152 | -18 | -1.5% | 418,200 |
2023/12/14 | 1,186 | 1,200 | 1,151 | 1,170 | ±0 | ±0% | 370,000 |
2023/12/13 | 1,165 | 1,184 | 1,149 | 1,170 | -1 | -0.1% | 337,400 |
2023/12/12 | 1,185 | 1,185 | 1,164 | 1,171 | -7 | -0.6% | 338,300 |
2023/12/11 | 1,183 | 1,203 | 1,168 | 1,178 | -4 | -0.3% | 411,200 |
2023/12/08 | 1,208 | 1,214 | 1,177 | 1,182 | -53 | -4.3% | 510,900 |
2023/12/07 | 1,257 | 1,269 | 1,233 | 1,235 | -23 | -1.8% | 330,800 |
2023/12/06 | 1,243 | 1,265 | 1,235 | 1,258 | +33 | +2.7% | 328,200 |
2023/12/05 | 1,250 | 1,274 | 1,225 | 1,225 | -26 | -2.1% | 310,600 |
2023/12/04 | 1,243 | 1,260 | 1,221 | 1,251 | -10 | -0.8% | 381,800 |
2023/12/01 | 1,324 | 1,325 | 1,261 | 1,261 | -63 | -4.8% | 453,400 |
2023/11/30 | 1,311 | 1,339 | 1,300 | 1,324 | +12 | +0.9% | 467,100 |
2023/11/29 | 1,317 | 1,330 | 1,305 | 1,312 | -8 | -0.6% | 241,900 |
2023/11/28 | 1,310 | 1,331 | 1,296 | 1,320 | +9 | +0.7% | 300,400 |
2023/11/27 | 1,308 | 1,338 | 1,303 | 1,311 | +4 | +0.3% | 269,000 |
2023/11/24 | 1,300 | 1,320 | 1,293 | 1,307 | +2 | +0.2% | 265,500 |
2023/11/22 | 1,261 | 1,313 | 1,256 | 1,305 | +40 | +3.2% | 382,000 |
2023/11/21 | 1,270 | 1,284 | 1,248 | 1,265 | -5 | -0.4% | 313,100 |
2023/11/20 | 1,252 | 1,288 | 1,247 | 1,270 | +22 | +1.8% | 357,200 |
2023/11/17 | 1,217 | 1,248 | 1,214 | 1,248 | +23 | +1.9% | 222,300 |
2023/11/16 | 1,262 | 1,270 | 1,222 | 1,225 | -43 | -3.4% | 388,500 |
2023/11/15 | 1,208 | 1,270 | 1,201 | 1,268 | +80 | +6.7% | 558,900 |
201~
250
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 69,600円 | -3.7% | -36.7% | 2.87% | 22.92倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 113,700円 | +197.7% | - | 0.00% | 46.47倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,100円 | +3.2% | +4.5% | 3.49% | 17.13倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 210,100円 | +0.4% | -8.4% | 2.52% | 27.77倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,700円 | - | - | 0.00% | - | 48.69倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム